Evidence map›Paper›PMID 28726761›Full record

ArticleJournal of functional biomaterials2017

A Cell-Adhesive Plasma Polymerized Allylamine Coating Reduces the In Vivo Inflammatory Response Induced by Ti6Al4V Modified with Plasma Immersion Ion Implantation of Copper.

Uwe Walschus, Andreas Hoene, Maciej Patrzyk, Silke Lucke, Birgit Finke, Martin Polak, Gerold Lukowski, Rainer Bader, Carmen Zietz, Andreas Podbielski and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Uwe WalschusResearch Group of Predictive Diagnostics, Department of Medical Biochemistry and Molecular Biology, University Medical Center Greifswald, 17475 Greifswald, Germany. uwe.walschus@uni-greifswald.de.
Andreas HoeneDepartment of Surgery, University Medical Center Greifswald, 17475 Greifswald, Germany. hoene@uni-greifswald.de.
Maciej PatrzykDepartment of Surgery, University Medical Center Greifswald, 17475 Greifswald, Germany. patrzyk@uni-greifswald.de.
Silke LuckeResearch Group of Predictive Diagnostics, Department of Medical Biochemistry and Molecular Biology, University Medical Center Greifswald, 17475 Greifswald, Germany. luckes@uni-greifswald.de.
Birgit FinkeLeibniz Institute for Plasma Science and Technology (INP), 17489 Greifswald, Germany. finke@inp-greifswald.de.
Martin PolakLeibniz Institute for Plasma Science and Technology (INP), 17489 Greifswald, Germany. polak@inp-greifswald.de.
Gerold LukowskiInstitute of Marine Biotechnology, 17489 Greifswald, Germany. lukowski@uni-greifswald.de.
Rainer BaderDepartment of Orthopaedics, University Medical Center Rostock, 18057 Rostock, Germany. rainer.bader@med.uni-rostock.de.
Carmen ZietzDepartment of Orthopaedics, University Medical Center Rostock, 18057 Rostock, Germany. carmen.zietz@med.uni-rostock.de.
Andreas PodbielskiDepartment of Medical Microbiology, Virology and Hospital Hygiene, University Medical Center Rostock, 18057 Rostock, Germany. andreas.podbielski@med.uni-rostock.de.
J Barbara NebeDepartment of Cell Biology, University Medical Center Rostock, 18057 Rostock, Germany. barbara.nebe@med.uni-rostock.de.
Michael SchlosserResearch Group of Predictive Diagnostics, Department of Medical Biochemistry and Molecular Biology, University Medical Center Greifswald, 17475 Greifswald, Germany. schlosse@uni-greifswald.de.
Universitätsmedizin Greifswald · DEUniversity of Rostock · DELeibniz Institute for Plasma Science and Technology · DEInstitute of Marine Biotechnology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper (Cu) could be suitable to create anti-infective implants based on Titanium (Ti), for example by incorporating Cu into the implant surface using plasma immersion ion implantation (Cu-PIII). The cytotoxicity of Cu might be circumvented by an additional cell-adhesive plasma polymerized allylamine film (PPAAm). Thus, this study aimed to examine in vivo local inflammatory reactions for Ti6Al4V implants treated with Cu-PIII (Ti-Cu), alone or with an additional PPAAm film (Ti-Cu-PPAAm), compared to untreated implants (Ti). Successful Cu-PIII and PPAAm treatment was confirmed with X-ray Photoelectron Spectroscopy. Storage of Ti-Cu and Ti-Cu-PPAAm samples in double-distilled water for five days revealed a reduction of Cu release by PPAAm. Subsequently, Ti, Ti-Cu and Ti-Cu-PPAAm samples were simultaneously implanted into the neck musculature of 24 rats. After 7, 14 and 56 days, peri-implant tissue was retrieved from 8 rats/day for morphometric immunohistochemistry of different inflammatory cells. On day 56, Ti-Cu induced significantly stronger reactions compared to Ti (tissue macrophages, antigen-presenting cells, T lymphocytes) and to Ti-Cu-PPAAm (tissue macrophages, T lymphocytes, mast cells). The response for Ti-Cu-PPAAm was comparable with Ti. In conclusion, PPAAm reduced the inflammatory reactions caused by Cu-PIII. Combining both plasma processes could be useful to create antibacterial and tissue compatible Ti-based implants.

Indexed as

antibacterial propertiesbiocompatibilitycopperinflammatory responsemorphometryplasma immersion ion implantationplasma polymerizationtitanium

Identifiers

PMID28726761
PMCPMC5618281
OpenAlexW2736416705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.